From Name:
From Email:
To Name:
To Email:

Optional Message:


Multiple sclerosis drug investigated after 11 deaths

from The Associated Press via The Washington Post

A European agency is investigating a multiple sclerosis drug made by industry giant Novartis to determine whether the medicine played any role in the deaths at least 11 patients. The drug, Gilenya, was licensed in the European Union to treat a severe type of multiple sclerosis. The European Medicines Agency, which is now investigating the drug, said it isn't clear if it caused the deaths. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063